Re: https://scr.zacks.co...

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: https://scr.zacks.co...

in response to

https://scr.zacks.co...

fuzzyjr

posted on May 04, 2020 11:39AM

Nice find Fuzzy. Glad to see Zenith getting some attention. At the same time, I no longer see Resverlogix on the list of covered companies for Zacks/SCR. John Vandermosten and Zacks were the most frequent to update their Resverlogix analysis.